144
Participants
Start Date
January 31, 2013
Primary Completion Date
June 30, 2016
Study Completion Date
December 31, 2017
lisinopril
"Angiotensin converting enzyme inhibitor recommended in case of:~1. hyperconstrictive profile (SVRI \> 2500-2800 dyn•s•cm-5•m2)~2. hyperdynamic profile (CI \> 4.2 l/min/m2 and/or HR \> 80/min) and office SBP ≥ 160 mm Hg and/or DBP ≥ 100 mmHg and/or 24-h mean SBP ≥ 140 mm Hg and/or 24-h mean DBP ≥ 90 mm Hg (in combination with nebivolol)~3. hypervolemic profile (man - TFC \> 34 1/kOhm; women - TFC \> 24 1/kOhm) and office SBP ≥ 160 mm Hg and/or DBP ≥ 100 mmHg and/or 24-h mean SBP ≥ 140 mm Hg and/or 24-h mean DBP ≥ 90 mm Hg (in combination with diuretic)~4. balanced profile"
Telmisartan
Angiotensin receptor blocker recommended in terms as for lisinopril in case of its intolerance (e.i. cough)
Nebivolol
"Beta-blocker recommended in case of:~1.hyperdynamic profile (CI \> 4.2 l/min/m2 and/or HR \> 80/min)"
Indapamide/hydrochlorothiazide
"1. hypervolemic profile (man - TFC \> 34 1/kOhm; women - TFC \> 24 1/kOhm)~2. hyperconstrictive profile (SVRI \> 2500-2800 dyn•s•cm-5•m2) and office SBP ≥ 160 mm Hg and/or DBP ≥ 100 mmHg and or 24-h mean SBP ≥ 140 mm Hg and/or 24-h mean DBP ≥ 90 mm Hg (in combination with lisinopril/telmisartan)"
Amlodipine
1/ SVRI \> 2800 dyn•s•cm-5•m2 (in combination with lisinopril/telmisartan)
lisinopril
Drug choice at the discretion of physician (blinded to ICG)
Telmisartan
Angiotensin receptor blocker recommended as for lisinopril in case of its intolerance (e.i. cough)
Nebivolol
Drug choice at the discretion of physician (blinded to ICG)
Indapamide/hydrochlorothiazide
Drug choice at the discretion of physician (blinded to ICG)
Amlodipine
Drug choice at the discretion of physician (blinded to ICG)
Military Institute of Medicine, Warsaw
Military Institute od Medicine National Research Institute
OTHER